USA FDA Gives Biogen Big Hand In Effort To Get Its Alzheimer’s Treatment On The Market

 
• By Brenda Sandburg
  
Silhouettes of two people climbing on mountain and helping
FDA collaborates with Biogen in preparting aducanumab Alzheimer's drug for BLA submission • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers